Turn this role into an interview — a resume and cover letter built around what this employer wants.
Fate Therapeutics, Inc. in San Diego, CA, seeks a Senior Manager, Regulatory Affairs CMC to shape global CMC regulatory strategy and lead high-quality submissions for cell therapy products from development through licensure.
The role requires a collaborative regulatory professional with strong CMC expertise, biotech/pharma experience, and excellent communication to influence cross-functional teams in a fast-paced environment. Located at corporate headquarters in San Diego.
Fate Therapeutics is looking for Senior Manager, Regulatory Affairs CMC to help advance innovative cell therapy products from early development through licensure. In this role, you will shape global CMC regulatory strategy, lead high-quality submissions, partner across technical and quality teams, and contribute to health authority interactions. The ideal candidate is a collaborative regulatory professional with strong CMC expertise, biotechnology or pharmaceutical experience, sound judgment, and the communication skills to influence cross‑functional teams in a fast‑paced, mission‑driven environment. This is a full‑time, exempt position located at our corporate headquarters in San Diego, CA.
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time.
Fate Therapeutics, Inc. is an equal opportunity employer. We value diversity and are committed to creating an inclusive environment for all employees.
To learn about how Fate collects and uses job application information, please visit Fate's online Privacy Notice.
Fate Therapeutics is a clinical‑stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed‑engineered master iPSC lines and in the manufacture and clinical development of off‑the‑shelf, iPSC‑derived cell products. The Company’s pipeline includes iPSC‑derived T‑cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.